Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare.

BACKGROUND: In breast cancer, diabetes diagnosed prior to cancer (previously diagnosed) is associated with advanced cancer stage and increased mortality. However, in the general population, 40% of diabetes is undiagnosed until glucose testing, and evidence suggests one consequence of increased eval...

Полное описание

Библиографические подробности
Главные авторы: Griffiths, R, Danese, MD, Gleeson, M, Valderas, J
Формат: Journal article
Язык:English
Опубликовано: BioMed Central 2012
Предметы:
_version_ 1826268548344840192
author Griffiths, R
Danese, MD
Gleeson, M
Valderas, J
author_facet Griffiths, R
Danese, MD
Gleeson, M
Valderas, J
author_sort Griffiths, R
collection OXFORD
description BACKGROUND: In breast cancer, diabetes diagnosed prior to cancer (previously diagnosed) is associated with advanced cancer stage and increased mortality. However, in the general population, 40% of diabetes is undiagnosed until glucose testing, and evidence suggests one consequence of increased evaluation and management around breast cancer diagnosis is the increased detection of previously undiagnosed diabetes. Biological factors - for instance, higher insulin levels due to untreated disease - and others underlying the association between previously diagnosed diabetes and breast cancer could differ in those whose diabetes remains undiagnosed until cancer. Our objectives were to identify factors associated with previously undiagnosed diabetes in breast cancer, and to examine associations between previously undiagnosed diabetes and cancer stage, treatment patterns, and mortality. METHODS: Using Surveillance, Epidemiology, and End Results-Medicare, we identified women diagnosed with breast cancer and diabetes between 01/2001 and 12/2005. Diabetes was classified as previously diagnosed if it was identified within Medicare claims between 24 and 4 months before cancer diagnosis, and previously undiagnosed if it was identified from 3 months before to ≤ 3 months after cancer. Patients were followed until 12/2007 or death, whichever came first. Multivariate analyses were performed to examine risk factors for previously undiagnosed diabetes and associations between undiagnosed (compared to previously diagnosed) diabetes, cancer stage, treatment, and mortality. RESULTS: Of 2,418 patients, 634 (26%) had previously undiagnosed diabetes; the remainder had previously diagnosed diabetes. The mean age was 77.8 years, and 49.4% were diagnosed with in situ or stage I disease. Age > 80 years (40% of the cohort) and limited health system contact (primary care physician and/or preventive services) prior to cancer were associated with higher adjusted odds of previously undiagnosed diabetes. Previously undiagnosed diabetes was associated with higher adjusted odds of advanced stage (III/IV) cancer (Odds Ratio = 1.37: 95% Confidence Interval (CI) 1.05 - 1.80; P = 0.02), and a higher adjusted mortality rate due to causes other than cancer (Hazard Ratio = 1.29; 95% CI 1.02 - 1.63; P = 0.03). CONCLUSIONS: In breast cancer, previously undiagnosed diabetes is associated with advanced stage cancer and increased mortality. Identifying biological factors would require further investigation.
first_indexed 2024-03-06T21:11:23Z
format Journal article
id oxford-uuid:3e4ad76f-82b4-478a-94f5-9db7c2a662a1
institution University of Oxford
language English
last_indexed 2024-03-06T21:11:23Z
publishDate 2012
publisher BioMed Central
record_format dspace
spelling oxford-uuid:3e4ad76f-82b4-478a-94f5-9db7c2a662a12022-03-26T14:24:38ZEpidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3e4ad76f-82b4-478a-94f5-9db7c2a662a1EpidemiologyOncologyDiabetesEnglishSymplectic Elements at OxfordBioMed Central2012Griffiths, RDanese, MDGleeson, MValderas, J BACKGROUND: In breast cancer, diabetes diagnosed prior to cancer (previously diagnosed) is associated with advanced cancer stage and increased mortality. However, in the general population, 40% of diabetes is undiagnosed until glucose testing, and evidence suggests one consequence of increased evaluation and management around breast cancer diagnosis is the increased detection of previously undiagnosed diabetes. Biological factors - for instance, higher insulin levels due to untreated disease - and others underlying the association between previously diagnosed diabetes and breast cancer could differ in those whose diabetes remains undiagnosed until cancer. Our objectives were to identify factors associated with previously undiagnosed diabetes in breast cancer, and to examine associations between previously undiagnosed diabetes and cancer stage, treatment patterns, and mortality. METHODS: Using Surveillance, Epidemiology, and End Results-Medicare, we identified women diagnosed with breast cancer and diabetes between 01/2001 and 12/2005. Diabetes was classified as previously diagnosed if it was identified within Medicare claims between 24 and 4 months before cancer diagnosis, and previously undiagnosed if it was identified from 3 months before to ≤ 3 months after cancer. Patients were followed until 12/2007 or death, whichever came first. Multivariate analyses were performed to examine risk factors for previously undiagnosed diabetes and associations between undiagnosed (compared to previously diagnosed) diabetes, cancer stage, treatment, and mortality. RESULTS: Of 2,418 patients, 634 (26%) had previously undiagnosed diabetes; the remainder had previously diagnosed diabetes. The mean age was 77.8 years, and 49.4% were diagnosed with in situ or stage I disease. Age > 80 years (40% of the cohort) and limited health system contact (primary care physician and/or preventive services) prior to cancer were associated with higher adjusted odds of previously undiagnosed diabetes. Previously undiagnosed diabetes was associated with higher adjusted odds of advanced stage (III/IV) cancer (Odds Ratio = 1.37: 95% Confidence Interval (CI) 1.05 - 1.80; P = 0.02), and a higher adjusted mortality rate due to causes other than cancer (Hazard Ratio = 1.29; 95% CI 1.02 - 1.63; P = 0.03). CONCLUSIONS: In breast cancer, previously undiagnosed diabetes is associated with advanced stage cancer and increased mortality. Identifying biological factors would require further investigation.
spellingShingle Epidemiology
Oncology
Diabetes
Griffiths, R
Danese, MD
Gleeson, M
Valderas, J
Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare.
title Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare.
title_full Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare.
title_fullStr Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare.
title_full_unstemmed Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare.
title_short Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare.
title_sort epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer an observational cohort study based on seer medicare
topic Epidemiology
Oncology
Diabetes
work_keys_str_mv AT griffithsr epidemiologyandoutcomesofpreviouslyundiagnoseddiabetesinolderwomenwithbreastcanceranobservationalcohortstudybasedonseermedicare
AT danesemd epidemiologyandoutcomesofpreviouslyundiagnoseddiabetesinolderwomenwithbreastcanceranobservationalcohortstudybasedonseermedicare
AT gleesonm epidemiologyandoutcomesofpreviouslyundiagnoseddiabetesinolderwomenwithbreastcanceranobservationalcohortstudybasedonseermedicare
AT valderasj epidemiologyandoutcomesofpreviouslyundiagnoseddiabetesinolderwomenwithbreastcanceranobservationalcohortstudybasedonseermedicare